SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 66.79   -6.13 (-8.41%) Volume: 745.86k 4:00 PM EDT 27-Mar-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities105/12/2017
10-QGeneral form for quarterly reports under Section 13 or 15(d)3905/09/2017
8-KCurrent report pursuant to Section 13 or 15(d)1205/09/2017
DEFA14AAdditional proxy soliciting materials - definitive504/14/2017
DEF 14AOther definitive proxy statements5204/14/2017
4Statement of changes in beneficial ownership of securities103/21/2017
4Statement of changes in beneficial ownership of securities103/10/2017
8-KCurrent report pursuant to Section 13 or 15(d)203/06/2017
4Statement of changes in beneficial ownership of securities103/03/2017
8-KCurrent report pursuant to Section 13 or 15(d)203/03/2017
4Statement of changes in beneficial ownership of securities102/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
4Statement of changes in beneficial ownership of securities102/28/2017
111213141516171819202122232425